NEW YORK, Oct. 22, 2019 /PRNewswire/ -- Cancer Therapies market worldwide is projected to grow by US$93.1 Billion, driven by a compounded growth of 7.9%. Chemotherapy, one of the segments analyzed and sized in this study, displays the potential to grow at over 8.6%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$74.8 Billion by the year 2025, Chemotherapy will bring in healthy gains adding significant momentum to global growth.
Read the full report: https://www.reportlinker.com/p05817674/?utm_source=PRN
- Representing the developed world, the United States will maintain a 6.7% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$3.2 Billion to the region's size and clout in the next 5 to 6 years. Over US$2.8 Billion worth of projected demand in the region will come from Rest of Europe markets. In Japan, Chemotherapy will reach a market size of US$3.6 Billion by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 11.8% over the next couple of years and add approximately US$26.1 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.
- Competitors identified in this market include among others, Amgen, Inc.; AstraZeneca plc; Bayer AG; Eli Lilly and Company; F. Hoffmann-La Roche AG; Johnson & Johnson; Merck & Co., Inc.; Novartis International AG; Pfizer, Inc.
Read the full report: https://www.reportlinker.com/p05817674/?utm_source=PRN
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Global Competitor Market Shares
Cancer Therapies Competitor Market Share Scenario Worldwide
(in %): 2019 & 2028
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: Cancer Therapies Global Market Estimates and Forecasts
in US$ Million by Region/Country: 2018-2025
Table 2: Cancer Therapies Global Retrospective Market Scenario
in US$ Million by Region/Country: 2009-2017
Table 3: Cancer Therapies Market Share Shift across Key
Geographies Worldwide: 2009 VS 2019 VS 2025
Table 4: Chemotherapy (Treatment Type) World Market by
Region/Country in US$ Million: 2018 to 2025
Table 5: Chemotherapy (Treatment Type) Historic Market Analysis
by Region/Country in US$ Million: 2009 to 2017
Table 6: Chemotherapy (Treatment Type) Market Share Breakdown
of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
Table 7: Targeted Therapy (Treatment Type) Potential Growth
Markets Worldwide in US$ Million: 2018 to 2025
Table 8: Targeted Therapy (Treatment Type) Historic Market
Perspective by Region/Country in US$ Million: 2009 to 2017
Table 9: Targeted Therapy (Treatment Type) Market Sales
Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
Table 10: Immunotherapy (Treatment Type) Geographic Market
Spread Worldwide in US$ Million: 2018 to 2025
Table 11: Immunotherapy (Treatment Type) Region Wise Breakdown
of Global Historic Demand in US$ Million: 2009 to 2017
Table 12: Immunotherapy (Treatment Type) Market Share
Distribution in Percentage by Region/Country: 2009 VS 2019 VS
2025
Table 13: Hormonal Therapy (Treatment Type) World Market
Estimates and Forecasts by Region/Country in US$ Million: 2018
to 2025
Table 14: Hormonal Therapy (Treatment Type) Market Historic
Review by Region/Country in US$ Million: 2009 to 2017
Table 15: Hormonal Therapy (Treatment Type) Market Share
Breakdown by Region/Country: 2009 VS 2019 VS 2025
Table 16: Other Treatment Types (Treatment Type) World Market
by Region/Country in US$ Million: 2018 to 2025
Table 17: Other Treatment Types (Treatment Type) Historic
Market Analysis by Region/Country in US$ Million: 2009 to 2017
Table 18: Other Treatment Types (Treatment Type) Market Share
Distribution in Percentage by Region/Country: 2009 VS 2019 VS
2025
Table 19: Blood Cancer (Cancer Type) World Market Estimates and
Forecasts in US$ Million by Region/Country: 2018 to 2025
Table 20: Blood Cancer (Cancer Type) Market Worldwide Historic
Review by Region/Country in US$ Million: 2009 to 2017
Table 21: Blood Cancer (Cancer Type) Market Percentage Share
Distribution by Region/Country: 2009 VS 2019 VS 2025
Table 22: Breast Cancer (Cancer Type) Market Opportunity
Analysis Worldwide in US$ Million by Region/Country: 2018 to
2025
Table 23: Breast Cancer (Cancer Type) Global Historic Demand in
US$ Million by Region/Country: 2009 to 2017
Table 24: Breast Cancer (Cancer Type) Market Share Distribution
in Percentage by Region/Country: 2009 VS 2019 VS 2025
Table 25: Prostate Cancer (Cancer Type) World Market by
Region/Country in US$ Million: 2018 to 2025
Table 26: Prostate Cancer (Cancer Type) Historic Market
Analysis by Region/Country in US$ Million: 2009 to 2017
Table 27: Prostate Cancer (Cancer Type) Market Share Breakdown
of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
Table 28: Gastrointestinal Cancer (Cancer Type) Potential
Growth Markets Worldwide in US$ Million: 2018 to 2025
Table 29: Gastrointestinal Cancer (Cancer Type) Historic Market
Perspective by Region/Country in US$ Million: 2009 to 2017
Table 30: Gastrointestinal Cancer (Cancer Type) Market Sales
Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
Table 31: Gynecologic Cancer (Cancer Type) Geographic Market
Spread Worldwide in US$ Million: 2018 to 2025
Table 32: Gynecologic Cancer (Cancer Type) Region Wise
Breakdown of Global Historic Demand in US$ Million: 2009 to
2017
Table 33: Gynecologic Cancer (Cancer Type) Market Share
Distribution in Percentage by Region/Country: 2009 VS 2019 VS
2025
Table 34: Respiratory/Lung Cancer (Cancer Type) World Market
Estimates and Forecasts by Region/Country in US$ Million: 2018
to 2025
Table 35: Respiratory/Lung Cancer (Cancer Type) Market Historic
Review by Region/Country in US$ Million: 2009 to 2017
Table 36: Respiratory/Lung Cancer (Cancer Type) Market Share
Breakdown by Region/Country: 2009 VS 2019 VS 2025
Table 37: Other Cancer Types (Cancer Type) World Market by
Region/Country in US$ Million: 2018 to 2025
Table 38: Other Cancer Types (Cancer Type) Historic Market
Analysis by Region/Country in US$ Million: 2009 to 2017
Table 39: Other Cancer Types (Cancer Type) Market Share
Distribution in Percentage by Region/Country: 2009 VS 2019 VS
2025
III. MARKET ANALYSIS
GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Cancer Therapies Market Share (in %) by Company: 2019 & 2025
Table 40: United States Cancer Therapies Market Estimates and
Projections in US$ Million by Treatment Type: 2018 to 2025
Table 41: Cancer Therapies Market in the United States by
Treatment Type: A Historic Review in US$ Million for 2009-2017
Table 42: United States Cancer Therapies Market Share Breakdown
by Treatment Type: 2009 VS 2019 VS 2025
Table 43: United States Cancer Therapies Market Estimates and
Projections in US$ Million by Cancer Type: 2018 to 2025
Table 44: Cancer Therapies Market in the United States by
Cancer Type: A Historic Review in US$ Million for 2009-2017
Table 45: United States Cancer Therapies Market Share Breakdown
by Cancer Type: 2009 VS 2019 VS 2025
CANADA
Table 46: Canadian Cancer Therapies Market Estimates and
Forecasts in US$ Million by Treatment Type: 2018 to 2025
Table 47: Canadian Cancer Therapies Historic Market Review by
Treatment Type in US$ Million: 2009-2017
Table 48: Cancer Therapies Market in Canada: Percentage Share
Breakdown of Sales by Treatment Type for 2009, 2019, and 2025
Table 49: Canadian Cancer Therapies Market Estimates and
Forecasts in US$ Million by Cancer Type: 2018 to 2025
Table 50: Canadian Cancer Therapies Historic Market Review by
Cancer Type in US$ Million: 2009-2017
Table 51: Cancer Therapies Market in Canada: Percentage Share
Breakdown of Sales by Cancer Type for 2009, 2019, and 2025
JAPAN
Table 52: Japanese Market for Cancer Therapies: Annual Sales
Estimates and Projections in US$ Million by Treatment Type for
the Period 2018-2025
Table 53: Cancer Therapies Market in Japan: Historic Sales
Analysis in US$ Million by Treatment Type for the Period
2009-2017
Table 54: Japanese Cancer Therapies Market Share Analysis by
Treatment Type: 2009 VS 2019 VS 2025
Table 55: Japanese Market for Cancer Therapies: Annual Sales
Estimates and Projections in US$ Million by Cancer Type for the
Period 2018-2025
Table 56: Cancer Therapies Market in Japan: Historic Sales
Analysis in US$ Million by Cancer Type for the Period 2009-2017
Table 57: Japanese Cancer Therapies Market Share Analysis by
Cancer Type: 2009 VS 2019 VS 2025
CHINA
Table 58: Chinese Cancer Therapies Market Growth Prospects in
US$ Million by Treatment Type for the Period 2018-2025
Table 59: Cancer Therapies Historic Market Analysis in China in
US$ Million by Treatment Type: 2009-2017
Table 60: Chinese Cancer Therapies Market by Treatment Type:
Percentage Breakdown of Sales for 2009, 2019, and 2025
Table 61: Chinese Cancer Therapies Market Growth Prospects in
US$ Million by Cancer Type for the Period 2018-2025
Table 62: Cancer Therapies Historic Market Analysis in China in
US$ Million by Cancer Type: 2009-2017
Table 63: Chinese Cancer Therapies Market by Cancer Type:
Percentage Breakdown of Sales for 2009, 2019, and 2025
EUROPE
Market Facts & Figures
European Cancer Therapies Market: Competitor Market Share
Scenario (in %) for 2019 & 2025
Table 64: European Cancer Therapies Market Demand Scenario in
US$ Million by Region/Country: 2018-2025
Table 65: Cancer Therapies Market in Europe: A Historic Market
Perspective in US$ Million by Region/Country for the Period
2009-2017
Table 66: European Cancer Therapies Market Share Shift by
Region/Country: 2009 VS 2019 VS 2025
Table 67: European Cancer Therapies Market Estimates and
Forecasts in US$ Million by Treatment Type: 2018-2025
Table 68: Cancer Therapies Market in Europe in US$ Million by
Treatment Type: A Historic Review for the Period 2009-2017
Table 69: European Cancer Therapies Market Share Breakdown by
Treatment Type: 2009 VS 2019 VS 2025
Table 70: European Cancer Therapies Market Estimates and
Forecasts in US$ Million by Cancer Type: 2018-2025
Table 71: Cancer Therapies Market in Europe in US$ Million by
Cancer Type: A Historic Review for the Period 2009-2017
Table 72: European Cancer Therapies Market Share Breakdown by
Cancer Type: 2009 VS 2019 VS 2025
FRANCE
Table 73: Cancer Therapies Market in France by Treatment Type:
Estimates and Projections in US$ Million for the Period
2018-2025
Table 74: French Cancer Therapies Historic Market Scenario in
US$ Million by Treatment Type: 2009-2017
Table 75: French Cancer Therapies Market Share Analysis by
Treatment Type: 2009 VS 2019 VS 2025
Table 76: Cancer Therapies Market in France by Cancer Type:
Estimates and Projections in US$ Million for the Period
2018-2025
Table 77: French Cancer Therapies Historic Market Scenario in
US$ Million by Cancer Type: 2009-2017
Table 78: French Cancer Therapies Market Share Analysis by
Cancer Type: 2009 VS 2019 VS 2025
GERMANY
Table 79: Cancer Therapies Market in Germany: Recent Past,
Current and Future Analysis in US$ Million by Treatment Type
for the Period 2018-2025
Table 80: German Cancer Therapies Historic Market Analysis in
US$ Million by Treatment Type: 2009-2017
Table 81: German Cancer Therapies Market Share Breakdown by
Treatment Type: 2009 VS 2019 VS 2025
Table 82: Cancer Therapies Market in Germany: Recent Past,
Current and Future Analysis in US$ Million by Cancer Type for
the Period 2018-2025
Table 83: German Cancer Therapies Historic Market Analysis in
US$ Million by Cancer Type: 2009-2017
Table 84: German Cancer Therapies Market Share Breakdown by
Cancer Type: 2009 VS 2019 VS 2025
ITALY
Table 85: Italian Cancer Therapies Market Growth Prospects in
US$ Million by Treatment Type for the Period 2018-2025
Table 86: Cancer Therapies Historic Market Analysis in Italy in
US$ Million by Treatment Type: 2009-2017
Table 87: Italian Cancer Therapies Market by Treatment Type:
Percentage Breakdown of Sales for 2009, 2019, and 2025
Table 88: Italian Cancer Therapies Market Growth Prospects in
US$ Million by Cancer Type for the Period 2018-2025
Table 89: Cancer Therapies Historic Market Analysis in Italy in
US$ Million by Cancer Type: 2009-2017
Table 90: Italian Cancer Therapies Market by Cancer Type:
Percentage Breakdown of Sales for 2009, 2019, and 2025
UNITED KINGDOM
Table 91: United Kingdom Market for Cancer Therapies: Annual
Sales Estimates and Projections in US$ Million by Treatment
Type for the Period 2018-2025
Table 92: Cancer Therapies Market in the United Kingdom:
Historic Sales Analysis in US$ Million by Treatment Type for
the Period 2009-2017
Table 93: United Kingdom Cancer Therapies Market Share Analysis
by Treatment Type: 2009 VS 2019 VS 2025
Table 94: United Kingdom Market for Cancer Therapies: Annual
Sales Estimates and Projections in US$ Million by Cancer Type
for the Period 2018-2025
Table 95: Cancer Therapies Market in the United Kingdom:
Historic Sales Analysis in US$ Million by Cancer Type for the
Period 2009-2017
Table 96: United Kingdom Cancer Therapies Market Share Analysis
by Cancer Type: 2009 VS 2019 VS 2025
SPAIN
Table 97: Spanish Cancer Therapies Market Estimates and
Forecasts in US$ Million by Treatment Type: 2018 to 2025
Table 98: Spanish Cancer Therapies Historic Market Review by
Treatment Type in US$ Million: 2009-2017
Table 99: Cancer Therapies Market in Spain: Percentage Share
Breakdown of Sales by Treatment Type for 2009, 2019, and 2025
Table 100: Spanish Cancer Therapies Market Estimates and
Forecasts in US$ Million by Cancer Type: 2018 to 2025
Table 101: Spanish Cancer Therapies Historic Market Review by
Cancer Type in US$ Million: 2009-2017
Table 102: Cancer Therapies Market in Spain: Percentage Share
Breakdown of Sales by Cancer Type for 2009, 2019, and 2025
RUSSIA
Table 103: Russian Cancer Therapies Market Estimates and
Projections in US$ Million by Treatment Type: 2018 to 2025
Table 104: Cancer Therapies Market in Russia by Treatment Type:
A Historic Review in US$ Million for 2009-2017
Table 105: Russian Cancer Therapies Market Share Breakdown by
Treatment Type: 2009 VS 2019 VS 2025
Table 106: Russian Cancer Therapies Market Estimates and
Projections in US$ Million by Cancer Type: 2018 to 2025
Table 107: Cancer Therapies Market in Russia by Cancer Type: A
Historic Review in US$ Million for 2009-2017
Table 108: Russian Cancer Therapies Market Share Breakdown by
Cancer Type: 2009 VS 2019 VS 2025
REST OF EUROPE
Table 109: Rest of Europe Cancer Therapies Market Estimates and
Forecasts in US$ Million by Treatment Type: 2018-2025
Table 110: Cancer Therapies Market in Rest of Europe in US$
Million by Treatment Type: A Historic Review for the Period
2009-2017
Table 111: Rest of Europe Cancer Therapies Market Share
Breakdown by Treatment Type: 2009 VS 2019 VS 2025
Table 112: Rest of Europe Cancer Therapies Market Estimates and
Forecasts in US$ Million by Cancer Type: 2018-2025
Table 113: Cancer Therapies Market in Rest of Europe in US$
Million by Cancer Type: A Historic Review for the Period
2009-2017
Table 114: Rest of Europe Cancer Therapies Market Share
Breakdown by Cancer Type: 2009 VS 2019 VS 2025
ASIA-PACIFIC
Table 115: Asia-Pacific Cancer Therapies Market Estimates and
Forecasts in US$ Million by Region/Country: 2018-2025
Table 116: Cancer Therapies Market in Asia-Pacific: Historic
Market Analysis in US$ Million by Region/Country for the Period
2009-2017
Table 117: Asia-Pacific Cancer Therapies Market Share Analysis
by Region/Country: 2009 VS 2019 VS 2025
Table 118: Cancer Therapies Market in Asia-Pacific by Treatment
Type: Estimates and Projections in US$ Million for the Period
2018-2025
Table 119: Asia-Pacific Cancer Therapies Historic Market
Scenario in US$ Million by Treatment Type: 2009-2017
Table 120: Asia-Pacific Cancer Therapies Market Share Analysis
by Treatment Type: 2009 VS 2019 VS 2025
Table 121: Cancer Therapies Market in Asia-Pacific by Cancer
Type: Estimates and Projections in US$ Million for the Period
2018-2025
Table 122: Asia-Pacific Cancer Therapies Historic Market
Scenario in US$ Million by Cancer Type: 2009-2017
Table 123: Asia-Pacific Cancer Therapies Market Share Analysis
by Cancer Type: 2009 VS 2019 VS 2025
AUSTRALIA
Table 124: Cancer Therapies Market in Australia: Recent Past,
Current and Future Analysis in US$ Million by Treatment Type
for the Period 2018-2025
Table 125: Australian Cancer Therapies Historic Market Analysis
in US$ Million by Treatment Type: 2009-2017
Table 126: Australian Cancer Therapies Market Share Breakdown
by Treatment Type: 2009 VS 2019 VS 2025
Table 127: Cancer Therapies Market in Australia: Recent Past,
Current and Future Analysis in US$ Million by Cancer Type for
the Period 2018-2025
Table 128: Australian Cancer Therapies Historic Market Analysis
in US$ Million by Cancer Type: 2009-2017
Table 129: Australian Cancer Therapies Market Share Breakdown
by Cancer Type: 2009 VS 2019 VS 2025
INDIA
Table 130: Indian Cancer Therapies Market Estimates and
Forecasts in US$ Million by Treatment Type: 2018 to 2025
Table 131: Indian Cancer Therapies Historic Market Review by
Treatment Type in US$ Million: 2009-2017
Table 132: Cancer Therapies Market in India: Percentage Share
Breakdown of Sales by Treatment Type for 2009, 2019, and 2025
Table 133: Indian Cancer Therapies Market Estimates and
Forecasts in US$ Million by Cancer Type: 2018 to 2025
Table 134: Indian Cancer Therapies Historic Market Review by
Cancer Type in US$ Million: 2009-2017
Table 135: Cancer Therapies Market in India: Percentage Share
Breakdown of Sales by Cancer Type for 2009, 2019, and 2025
SOUTH KOREA
Table 136: Cancer Therapies Market in South Korea: Recent Past,
Current and Future Analysis in US$ Million by Treatment Type
for the Period 2018-2025
Table 137: South Korean Cancer Therapies Historic Market
Analysis in US$ Million by Treatment Type: 2009-2017
Table 138: Cancer Therapies Market Share Distribution in South
Korea by Treatment Type: 2009 VS 2019 VS 2025
Table 139: Cancer Therapies Market in South Korea: Recent Past,
Current and Future Analysis in US$ Million by Cancer Type for
the Period 2018-2025
Table 140: South Korean Cancer Therapies Historic Market
Analysis in US$ Million by Cancer Type: 2009-2017
Table 141: Cancer Therapies Market Share Distribution in South
Korea by Cancer Type: 2009 VS 2019 VS 2025
REST OF ASIA-PACIFIC
Table 142: Rest of Asia-Pacific Market for Cancer Therapies:
Annual Sales Estimates and Projections in US$ Million by
Treatment Type for the Period 2018-2025
Table 143: Cancer Therapies Market in Rest of Asia-Pacific:
Historic Sales Analysis in US$ Million by Treatment Type for
the Period 2009-2017
Table 144: Rest of Asia-Pacific Cancer Therapies Market Share
Analysis by Treatment Type: 2009 VS 2019 VS 2025
Table 145: Rest of Asia-Pacific Market for Cancer Therapies:
Annual Sales Estimates and Projections in US$ Million by Cancer
Type for the Period 2018-2025
Table 146: Cancer Therapies Market in Rest of Asia-Pacific:
Historic Sales Analysis in US$ Million by Cancer Type for the
Period 2009-2017
Table 147: Rest of Asia-Pacific Cancer Therapies Market Share
Analysis by Cancer Type: 2009 VS 2019 VS 2025
LATIN AMERICA
Table 148: Latin American Cancer Therapies Market Trends by
Region/Country in US$ Million: 2018-2025
Table 149: Cancer Therapies Market in Latin America in US$
Million by Region/Country: A Historic Perspective for the
Period 2009-2017
Table 150: Latin American Cancer Therapies Market Percentage
Breakdown of Sales by Region/Country: 2009, 2019, and 2025
Table 151: Latin American Cancer Therapies Market Growth
Prospects in US$ Million by Treatment Type for the Period
2018-2025
Table 152: Cancer Therapies Historic Market Analysis in Latin
America in US$ Million by Treatment Type: 2009-2017
Table 153: Latin American Cancer Therapies Market by Treatment
Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
Table 154: Latin American Cancer Therapies Market Growth
Prospects in US$ Million by Cancer Type for the Period
2018-2025
Table 155: Cancer Therapies Historic Market Analysis in Latin
America in US$ Million by Cancer Type: 2009-2017
Table 156: Latin American Cancer Therapies Market by Cancer
Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
ARGENTINA
Table 157: Argentinean Cancer Therapies Market Estimates and
Forecasts in US$ Million by Treatment Type: 2018-2025
Table 158: Cancer Therapies Market in Argentina in US$ Million
by Treatment Type: A Historic Review for the Period 2009-2017
Table 159: Argentinean Cancer Therapies Market Share Breakdown
by Treatment Type: 2009 VS 2019 VS 2025
Table 160: Argentinean Cancer Therapies Market Estimates and
Forecasts in US$ Million by Cancer Type: 2018-2025
Table 161: Cancer Therapies Market in Argentina in US$ Million
by Cancer Type: A Historic Review for the Period 2009-2017
Table 162: Argentinean Cancer Therapies Market Share Breakdown
by Cancer Type: 2009 VS 2019 VS 2025
BRAZIL
Table 163: Cancer Therapies Market in Brazil by Treatment Type:
Estimates and Projections in US$ Million for the Period
2018-2025
Table 164: Brazilian Cancer Therapies Historic Market Scenario
in US$ Million by Treatment Type: 2009-2017
Table 165: Brazilian Cancer Therapies Market Share Analysis by
Treatment Type: 2009 VS 2019 VS 2025
Table 166: Cancer Therapies Market in Brazil by Cancer Type:
Estimates and Projections in US$ Million for the Period
2018-2025
Table 167: Brazilian Cancer Therapies Historic Market Scenario
in US$ Million by Cancer Type: 2009-2017
Table 168: Brazilian Cancer Therapies Market Share Analysis by
Cancer Type: 2009 VS 2019 VS 2025
MEXICO
Table 169: Cancer Therapies Market in Mexico: Recent Past,
Current and Future Analysis in US$ Million by Treatment Type
for the Period 2018-2025
Table 170: Mexican Cancer Therapies Historic Market Analysis in
US$ Million by Treatment Type: 2009-2017
Table 171: Mexican Cancer Therapies Market Share Breakdown by
Treatment Type: 2009 VS 2019 VS 2025
Table 172: Cancer Therapies Market in Mexico: Recent Past,
Current and Future Analysis in US$ Million by Cancer Type for
the Period 2018-2025
Table 173: Mexican Cancer Therapies Historic Market Analysis in
US$ Million by Cancer Type: 2009-2017
Table 174: Mexican Cancer Therapies Market Share Breakdown by
Cancer Type: 2009 VS 2019 VS 2025
REST OF LATIN AMERICA
Table 175: Rest of Latin America Cancer Therapies Market
Estimates and Projections in US$ Million by Treatment Type:
2018 to 2025
Table 176: Cancer Therapies Market in Rest of Latin America by
Treatment Type: A Historic Review in US$ Million for 2009-2017
Table 177: Rest of Latin America Cancer Therapies Market Share
Breakdown by Treatment Type: 2009 VS 2019 VS 2025
Table 178: Rest of Latin America Cancer Therapies Market
Estimates and Projections in US$ Million by Cancer Type: 2018
to 2025
Table 179: Cancer Therapies Market in Rest of Latin America by
Cancer Type: A Historic Review in US$ Million for 2009-2017
Table 180: Rest of Latin America Cancer Therapies Market Share
Breakdown by Cancer Type: 2009 VS 2019 VS 2025
MIDDLE EAST
Table 181: The Middle East Cancer Therapies Market Estimates
and Forecasts in US$ Million by Region/Country: 2018-2025
Table 182: Cancer Therapies Market in the Middle East by
Region/Country in US$ Million: 2009-2017
Table 183: The Middle East Cancer Therapies Market Share
Breakdown by Region/Country: 2009, 2019, and 2025
Table 184: The Middle East Cancer Therapies Market Estimates
and Forecasts in US$ Million by Treatment Type: 2018 to 2025
Table 185: The Middle East Cancer Therapies Historic Market by
Treatment Type in US$ Million: 2009-2017
Table 186: Cancer Therapies Market in the Middle East:
Percentage Share Breakdown of Sales by Treatment Type for
2009, 2019, and 2025
Table 187: The Middle East Cancer Therapies Market Estimates
and Forecasts in US$ Million by Cancer Type: 2018 to 2025
Table 188: The Middle East Cancer Therapies Historic Market by
Cancer Type in US$ Million: 2009-2017
Table 189: Cancer Therapies Market in the Middle East:
Percentage Share Breakdown of Sales by Cancer Type for 2009,
2019, and 2025
IRAN
Table 190: Iranian Market for Cancer Therapies: Annual Sales
Estimates and Projections in US$ Million by Treatment Type for
the Period 2018-2025
Table 191: Cancer Therapies Market in Iran: Historic Sales
Analysis in US$ Million by Treatment Type for the Period
2009-2017
Table 192: Iranian Cancer Therapies Market Share Analysis by
Treatment Type: 2009 VS 2019 VS 2025
Table 193: Iranian Market for Cancer Therapies: Annual Sales
Estimates and Projections in US$ Million by Cancer Type for the
Period 2018-2025
Table 194: Cancer Therapies Market in Iran: Historic Sales
Analysis in US$ Million by Cancer Type for the Period 2009-2017
Table 195: Iranian Cancer Therapies Market Share Analysis by
Cancer Type: 2009 VS 2019 VS 2025
ISRAEL
Table 196: Israeli Cancer Therapies Market Estimates and
Forecasts in US$ Million by Treatment Type: 2018-2025
Table 197: Cancer Therapies Market in Israel in US$ Million by
Treatment Type: A Historic Review for the Period 2009-2017
Table 198: Israeli Cancer Therapies Market Share Breakdown by
Treatment Type: 2009 VS 2019 VS 2025
Table 199: Israeli Cancer Therapies Market Estimates and
Forecasts in US$ Million by Cancer Type: 2018-2025
Table 200: Cancer Therapies Market in Israel in US$ Million by
Cancer Type: A Historic Review for the Period 2009-2017
Table 201: Israeli Cancer Therapies Market Share Breakdown by
Cancer Type: 2009 VS 2019 VS 2025
SAUDI ARABIA
Table 202: Saudi Arabian Cancer Therapies Market Growth
Prospects in US$ Million by Treatment Type for the Period
2018-2025
Table 203: Cancer Therapies Historic Market Analysis in Saudi
Arabia in US$ Million by Treatment Type: 2009-2017
Table 204: Saudi Arabian Cancer Therapies Market by Treatment
Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
Table 205: Saudi Arabian Cancer Therapies Market Growth
Prospects in US$ Million by Cancer Type for the Period
2018-2025
Table 206: Cancer Therapies Historic Market Analysis in Saudi
Arabia in US$ Million by Cancer Type: 2009-2017
Table 207: Saudi Arabian Cancer Therapies Market by Cancer
Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
UNITED ARAB EMIRATES
Table 208: Cancer Therapies Market in the United Arab Emirates:
Recent Past, Current and Future Analysis in US$ Million by
Treatment Type for the Period 2018-2025
Table 209: United Arab Emirates Cancer Therapies Historic
Market Analysis in US$ Million by Treatment Type: 2009-2017
Table 210: Cancer Therapies Market Share Distribution in United
Arab Emirates by Treatment Type: 2009 VS 2019 VS 2025
Table 211: Cancer Therapies Market in the United Arab Emirates:
Recent Past, Current and Future Analysis in US$ Million by
Cancer Type for the Period 2018-2025
Table 212: United Arab Emirates Cancer Therapies Historic
Market Analysis in US$ Million by Cancer Type: 2009-2017
Table 213: Cancer Therapies Market Share Distribution in United
Arab Emirates by Cancer Type: 2009 VS 2019 VS 2025
REST OF MIDDLE EAST
Table 214: Cancer Therapies Market in Rest of Middle East:
Recent Past, Current and Future Analysis in US$ Million by
Treatment Type for the Period 2018-2025
Table 215: Rest of Middle East Cancer Therapies Historic Market
Analysis in US$ Million by Treatment Type: 2009-2017
Table 216: Rest of Middle East Cancer Therapies Market Share
Breakdown by Treatment Type: 2009 VS 2019 VS 2025
Table 217: Cancer Therapies Market in Rest of Middle East:
Recent Past, Current and Future Analysis in US$ Million by
Cancer Type for the Period 2018-2025
Table 218: Rest of Middle East Cancer Therapies Historic Market
Analysis in US$ Million by Cancer Type: 2009-2017
Table 219: Rest of Middle East Cancer Therapies Market Share
Breakdown by Cancer Type: 2009 VS 2019 VS 2025
AFRICA
Table 220: African Cancer Therapies Market Estimates and
Projections in US$ Million by Treatment Type: 2018 to 2025
Table 221: Cancer Therapies Market in Africa by Treatment Type:
A Historic Review in US$ Million for 2009-2017
Table 222: African Cancer Therapies Market Share Breakdown by
Treatment Type: 2009 VS 2019 VS 2025
Table 223: African Cancer Therapies Market Estimates and
Projections in US$ Million by Cancer Type: 2018 to 2025
Table 224: Cancer Therapies Market in Africa by Cancer Type: A
Historic Review in US$ Million for 2009-2017
Table 225: African Cancer Therapies Market Share Breakdown by
Cancer Type: 2009 VS 2019 VS 2025
IV. COMPETITION
AMGEN
ASTRAZENECA PLC
BAYER AG
ELI LILLY AND COMPANY
F. HOFFMANN-LA ROCHE AG
JOHNSON & JOHNSON
MERCK & CO., INC.
NOVARTIS INTERNATIONAL AG
PFIZER
V. CURATED RESEARCH
Read the full report: https://www.reportlinker.com/p05817674/?utm_source=PRN
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001
SOURCE Reportlinker
Share this article